Clinical Trial Update: Imatinib in Acute Ischaemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating imatinib for acute ischemic stroke; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Niaz Ahmed | Conditions: Acute Ischaemic Stroke | Phase 3 | Status: UNKNOWN